North America Diabetes Care Devices Market expected to reach US$ 15,300.0 Mn with a CAGR of 6.3% in 2027 | The Insight Partners

North America Diabetes Care Devices Market to 2027 - Regional Analysis and Forecasts by Product (Glucose Monitoring Devices and Insulin Delivery Devices); End User (Homecare and Hospitals & Clinics); and Country

Publication Month: Jun 2019 | Report Code: TIPRE00005738 | No. of Pages: 140 | Category: Medical Device | Status: Published

The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

 

The growth of the market is driven by the factors such as, growing geriatric population and rapid technological advancements in diabetes care devices. However, the market is likely to get impacted due to high cost of diabetes care devices and risks associated with the insulin delivery devices in the region.

 

The pen needles attached to injection pens have been found to be re-used by the patients at a significant rate. One of the major reason behind this reuse is known to be the cost of these needles. Although the initial price of these pen needles are on a cheaper side, the existing prices are still a reason for lesser number of units sold as compared to the doses administered by patients on an average. According to a survey conducted by BD in determining the pattern of pen needle usage among population in 2014-2015, 23.3% participants in the survey reported reuse of pen needles due to the price of these needles as well as for cost-saving purposes. Thus, the market launch of affordable yet efficient pen needles is expected to be one of the potential opportunities that can be utilized by the market players to increase their sales and thereby establish a significant position in the highly competitive pen needles market. Few of the top companies have also started taking steps towards development and launch of such products in the market. For instance, in July 2017, Becton, Dickinson and Company (BD), as a part of action of the Health Service Medical Supplies Act 2017, launched Viva insulin pen needles as a cost effective option for people with diabetes to accommodate extreme budgetary pressure on the National Health Services (NHS). The company aimed to ensure presence of cost-effective options for high-quality pen needles in the UK. Various similar launches are expected to provide growth opportunities to emerging and local players in the global pen needles market.

 

US is expected to lead the market in the North America region owing to rise in the prevalence of the diabetes and growing elder population in the region. However, the country lags behind the other developed countries that can be a restrain to the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

 

NORTH AMERICA DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

  • Glucose Monitoring Devices
    • Glucometers
    • Lancets
    • Testing Strips
    • Other Glucose Monitoring Devices
  • Insulin Delivery Devices
    • Insulin Pens
    • Insulin Syringes
    • Insulin Pumps
    • Other Insulin Delivery Devices

By End User

  • Hospitals & Clinics
  • Homecare

 

 

By Geography

  • North America
    • US
    • Canada
    • Mexico

Company Profiles

  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Insulet Corporation
  • Medtronic
  • Tandem Diabetes Care, Inc.
  • Eli Lilly and Company
  • Dexcom, Inc.
  • Terumo Corporation
  • F. Hoffman-LA Roche Ltd.

PART 1.       iNTRODUCTION

1.1            Scope of the Study

1.2            The Insight Partners Research Report Guidance

PART 2.       North America DIABETES CARE DEVICES Market – Key takeaways

PART 3.       North America diabetes care devices market – market landscape

3.1            overview

3.2            market segmentation

3.2.1          North America Diabetes Care Devices Market – By Product

3.2.2          North America Diabetes Care Devices Market – By End User

3.2.3          North America Diabetes Care Devices Market – By Country

3.3            PEST Analysis

PART 4.       North America diabetes care devices market - Key Market Dynamics

4.1            Key Market Drivers

4.1.1          Growing Geriatric Population

4.1.2          Rapid Technological Advancements in Diabetes Care Devices

4.2            Key Market Restraints

4.2.1          High Cost of Diabetes Care Devices

4.2.2          Risks Associated with the Insulin Delivery Devices

4.3            Key Market Opportunities

4.3.1          Development of Cost Efficient Pen Needles

4.4            future Trends

4.4.1          Growing Product Innovations

4.5            Impact analysis

PART 5.       DIABETES CARE DEVICES market – North America Analysis

5.1            North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis

5.2            Market positioning

5.3            PERFORMANCE OF KEY PLAYERS

5.3.1          Medtronic

5.3.2          F. Hoffmann-La Roche Ltd.

PART 6.       North America DIABETES CARE DEVICES market Analysis – By Product

6.1            overview

6.2            North America diabetes care devices Market BY Product, 2018 & 2027 (%)

6.3            North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.3.1          North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.3.2          North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

6.4            Glucose Monitoring Devices Market

6.4.1          Overview

6.4.2          North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.4.3          Glucometers Market

6.4.3.1      Overview

6.4.3.2      North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)

6.4.4          Lancets Market

6.4.4.1      Overview

6.4.4.2      North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)

6.4.5          Testing Strips Market

6.4.5.1      Overview

6.4.5.2      North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)

6.4.6          Other Glucose Monitoring Devices Market

6.4.6.1      Overview

6.4.6.2      North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5            Insulin Delivery Devices Market

6.5.1          Overview

6.5.2          North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3          Insulin Pens Market

6.5.3.1      Overview

6.5.3.2      North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4          Insulin Syringes Market

6.5.4.1      Overview

6.5.4.2      North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)

6.5.5          Insulin Pumps Market

6.5.5.1      Overview

6.5.5.2      North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)

6.5.6          Other Insulin Delivery Devices Market

6.5.6.1      Overview

6.5.6.2      North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

PART 7.       North America diabetes care devices market Analysis – By End User

7.1            Overview

7.2            NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End User, 2018 & 2027 (%)

7.3            North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)

7.4            Homecare MArket

7.4.1          Overview

7.4.2          North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)

7.5            hospitals & Clinics Market

7.5.1          Overview

7.5.2          North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

PART 8.       North America diabetes care devices market Revenue and Forecasts to 2027

8.1            Overview

8.2            North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.3            North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.1          North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.3.2          North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.4            North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)

8.5            North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)

8.6            US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)

8.6.1          US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.2          US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.6.2.1      US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.2.2      US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.6.3          US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

8.7            Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.1          Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.2          Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.7.2.1      Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.2.2      Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.7.3          Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

8.8            Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.1          Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.2          Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.8.2.1      Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.2.2      Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

8.8.3          Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

PART 9.       diabetes care devices market – Industry Landscape

9.1            Overview

9.2            Comparative Company Analysis

9.3            Growth Strategies done by the companies in the Market, (%)

9.4            Organic Developments

9.4.1          Overview

9.5            Inorganic developments

9.5.1          Overview

PART 10.    DIABETES CARE DEVICES Market–Key company profiles

10.1         BD

10.1.1       Key Facts

10.1.2       Business Description

10.1.3       Financial Overview

10.1.4       Product Portfolio

10.1.5       SWOT Analysis

10.1.6       Key Developments

10.2         novo nordisk a/s

10.2.1       Key Facts

10.2.2       Business Description

10.2.3       Financial Overview

10.2.4       Product Portfolio

10.2.5       SWOT Analysis

10.2.6       Key Developments

10.3         B. Braun Melsungen AG

10.3.1       Key Facts

10.3.2       Business Description

10.3.3       Financial Overview

10.3.4       Product Portfolio

10.3.5       SWOT Analysis

10.3.6       Key Developments

10.4         Medtronic

10.4.1       Key Facts

10.4.2       Business Description

10.4.3       Financial Information

10.4.4       Product Portfolio

10.4.5       SWOT Analysis

10.4.6       Key Developments

10.5         Tandem Diabetes Care, Inc.

10.5.1       Key Facts

10.5.2       Business Description

10.5.3       Financial Information

10.5.4       Product Portfolio

10.5.5       SWOT Analysis

10.5.6       Key Developments

10.6         Insulet Corporation

10.6.1       Key Facts

10.6.2       Business Description

10.6.3       Financial Information

10.6.4       Product Portfolio

10.6.5       SWOT Analysis

10.6.6       Key Developments

10.7         Eli lilly and company

10.7.1       Key Facts

10.7.2       Business Description

10.7.3       Financial Overview

10.7.4       Product Portfolio

10.7.5       SWOT Analysis

10.7.6       Key Developments

10.8         Dexcom, Inc.

10.8.1       Key Facts

10.8.2       Business Description

10.8.3       Financial Overview

10.8.4       Product Portfolio

10.8.5       SWOT Analysis

10.8.6       Key Developments

10.9         Terumo Corporation

10.9.1       Key Facts

10.9.2       Business Description

10.9.3       Financial Overview

10.9.4       Product portfolio

10.9.5       SWOT ANALYSIS

10.9.6       KEY DEVELOPMENTS

10.10      F. Hoffmann-La Roche Ltd.

10.10.1     Key Facts

10.10.2     Business Description

10.10.3     Financial Overview

10.10.4     Product Portfolio

10.10.5     SWOT Analysis

10.10.6     Key Developments

PART 11.    Appendix

11.1         About The Insight Partners

11.2         Glossary of Terms

11.3         Methodology

11.3.1       Coverage

11.3.2       Secondary Research

11.3.3       Primary Research

LIST OF TABLES

TABLE 1.           total number of persons ofaged 60 years or above by region, 2017 & 2050

TABLE 2.           North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 3.           North America Glucose Monitoring Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 4.           North America Insulin Delivery Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 5.           North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 6.           North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 7.           North America Glucose Monitoring Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8.           North America Insulin Delivery Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 9.           North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 10.        US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 11.        US glucose monitoring Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 12.        US insulin delivery Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 13.        US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 14.        Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 15.        Canada glucose monitoring Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 16.        Canada insulin delivery Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 17.        Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 18.        Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 19.        Mexico glucose monitoring Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 20.        Mexico insulin delivery Devices Market Revenue And Forecasts to 2027, By type (US$ Mn)

TABLE 21.        Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

TABLE 22.        Organic Developments Done By Companies

TABLE 23.        Inorganic developments done by Companies

TABLE 24.        Glossary of Terms, DIABETES CARE DEVICES market

LIST OF FIGURES

FIGURE 1.        US diabetes care devices market, Revenue (US$ Mn), By COuntry 2018 & 2027. 19

FIGURE 2.        North America diabetes care devices market By Product, Market Share (%), 2018. 20

FIGURE 3.        North America Diabetes care Devices market By End User, Market Share (%), 2018. 21

FIGURE 4.        diabetes care devices market Segmentation.. 23

FIGURE 5.        North America PEST Analysis. 25

FIGURE 6.        diabetes care devices market impact analysis of drivers & Restraints. 33

FIGURE 7.        North America DIABETES CARE DEVICES market – Revenue Forecasts and Analysis – 2018- 2027. 35

FIGURE 8.        North America DIABETES CARE DEVICES Market, by product 2018 & 2027 (%) 38

FIGURE 9.        North America GLucose Monitoring Devices Market Revenue and Forecasts to 2027 (US$ Mn) 42

FIGURE 10.     North America Glucometers Market Revenue and Forecasts to 2027 (US$ Mn) 44

FIGURE 11.     North America lancets Market Revenue and Forecasts to 2027 (US$ Mn) 46

FIGURE 12.     North America testing strips Market Revenue and Forecasts to 2027 (US$ Mn) 48

FIGURE 13.     North America other glucose monitoring devices Market Revenue and Forecasts to 2027 (US$ Mn) 50

FIGURE 14.     North America insulin delivery devices Market Revenue and Forecasts to 2027 (US$ Mn) 52

FIGURE 15.     NORTH AMERICA insulin pens Market Revenue and Forecasts to 2027 (US$ Mn) 54

FIGURE 16.     North America insulin syringes Market Revenue and Forecasts to 2027 (US$ Mn) 56

FIGURE 17.     North America insulin pumps Market Revenue and Forecasts to 2027 (US$ Mn) 58

FIGURE 18.     North America insulin delivery devices Market Revenue and Forecasts to 2027 (US$ Mn) 60

FIGURE 19.     North America DIABETES CARE DEVICES market By End User, 2018 & 2027 (%) 61

FIGURE 20.     North America homecare Market Revenue and Forecasts to 2027 (US$ Mn) 64

FIGURE 21.     North America hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 66

FIGURE 22.     North America diabetes care devices market REVENUE overview, by Country, 2018 (US$ MN) 68

FIGURE 23.     North America DIABETES CARE DEVICES Market Revenue and Forecasts to 2027 (US$ Mn) 69

FIGURE 24.     North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%) 72

FIGURE 25.     US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 74

FIGURE 26.     Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 78

FIGURE 27.     Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn) 82

FIGURE 28.     Comparative Company Analysis. 85

FIGURE 29.     Growth Strategies done by the companies in the Market, (%) 86

 

 

The List of Companies

  1. BD
  2. Novo Nordisk A/S
  3. B. Braun Melsungen AG
  4. Insulet Corporation
  5. Medtronic
  6. Tandem Diabetes Care, Inc.
  7. Eli Lilly and Company
  8. Dexcom, Inc.
  9. Terumo Corporation
  10. F. Hoffman-LA Roche Ltd.